Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PersonGen Anke Cellular Therapeutics
Hefei, Anhui, Chinapersongen-anke.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
PersonGen Anke Cellular Therapeutics is a high-tech joint venture established by PersonGen Biotherapeutics and Anhui Anke Biotechnology. The company focuses on the development and commercialization of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for both hematological malignancies and solid tumors. Its lead program, PA3-17, is a CD19-targeted CAR-T cell injection that has advanced into pivotal clinical trials in China for relapsed or refractory B-cell acute lymphoblastic leukemia. The company operates a large-scale, state-of-the-art GMP manufacturing facility in Hefei, designed to support the clinical and commercial supply of advanced cellular immunotherapies.
- Therapeutic areas
- Oncology
- Modalities
- CAR-T cell therapyCell therapy
- Industry
- Biotech
02
Partnerships
PersonGen BiotherapeuticsAnhui Anke Biotechnology (Group) Co., Ltd.
Beyond the preview
Go deeper on PersonGen Anke Cellular Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PersonGen Anke Cellular Therapeutics.